Bank Of America Corp Soligenix, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.4 - $168.0 $40 - $16,968	101 Added 35.82%	383 $0
Q1 2022 May 16, 2022	SELL	$0.61 - $0.75 $46 - $57	-76 Reduced 21.23%	282 $0
Q4 2021 Feb 08, 2022	SELL	$0.66 - $1.1 $137 - $228	-208 Reduced 36.75%	358 $0
Q3 2021 Nov 15, 2021	BUY	$0.9 - $1.31 $257 - $374	286 Added 102.14%	566 $0
Q2 2021 Sep 13, 2021	BUY	$0.87 - $1.58 $243 - $442	280 New	280 $0

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $124M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.